Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Benzinga
2025.07.25 12:34
portai
I'm PortAI, I can summarize articles.

U.S. stock futures were mixed, with Dow futures up 0.1%. Intel shares fell 5.9% in pre-market trading after reporting a second-quarter loss and announcing workforce reductions. Absci Corporation dropped 13.7% following a public offering announcement, while AST SpaceMobile fell 9.2% after a $500 million private offering. Other notable declines included Almonty Industries (-8.5%), Synovus Financial (-8.3%), and Sarepta Therapeutics (-5.2%) after a Sell rating from Citigroup. Overall, several stocks are moving lower in pre-market trading.

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.

Shares of Intel Corporation INTC fell in pre-market trading following second-quarter results.

Intel reported a loss for the second quarter, while sales topped estimates. Intel expects third-quarter revenue to be in the range of $12.6 billion to $13.6 billion, versus estimates of $12.63 billion. The company anticipates a third-quarter loss of 24 cents per share versus estimates for a loss of 18 cents per share. Intel CEO Lip-Bu Tan shared a memo with employees saying that the company will reduce its workforce to 75,000 employees by the end of the year through layoffs and attrition.

Intel shares dipped 5.9% to $21.30 in the pre-market trading session.

Trending Investment Opportunities

Here are some other stocks moving lower in pre-market trading.

  • Absci Corporation ABSI declined 13.7% to $3.03 in pre-market trading after the company announced the pricing of public offering of common stock.
  • AST SpaceMobile, Inc. ASTS fell 9.2% to $54.56 in pre-market trading after the company announced a $500 million private offering of convertible senior notes.
  • Almonty Industries Inc. ALM dipped 8.5% to $4.06 in pre-market trading.
  • Synovus Financial Corp. SNV fell 8.3% to $51.88 in pre-market trading. Pinnacle and Synovus announced an $8.6 billion all-stock merger.
  • Sarepta Therapeutics, Inc. SRPT declined 5.2% to $12.20 in pre-market trading. Citigroup analyst Yigal Nochomovitz, on Thursday, initiated coverage on Sarepta Therapeutics with a Sell rating and announced a price target of $7.
  • ABIVAX Société Anonyme ABVX fell 4% to $66.99 in pre-market trading. Abivax announced full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5 million (€637.5 million).
  • Semler Scientific, Inc. SMLR fell 3.6% to $37.50 in pre-market trading.

Now Read This:

  • Top 2 Tech Stocks You May Want To Dump This Quarter

Photo via Shutterstock

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.